Labstyle Innovations Corp (DRIO) 0.3100 $DRIO
LabStyle Innovations to Present at Health 2.0's 9th Annual Fall Conference in Silicon Valley on October 7, 2015
PR Newswire - Wed Sep 30, 7:30AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that its Executive Vice President of U.S. Operations, Todd Durniak, will deliver a demonstration of the Dario Solution at Health 2.0's 9th Annual Fall Conference in Santa Clara, California on Wednesday, October 7, 2015 at 10:45 am PT.
Executive VP of LabStyle Innovations Discusses Firm's Innovative Blood Glucose Testing Technology and His Firm's Current Value Proposition
ACCESSWIRE - Thu Sep 24, 8:01AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 24, 2015 / BioMedReports editor, M.E. Garza recently met with LabStyle Innovations Corp. (OTCQB: DRIO), new Executive Vice President and General Manager of US sales, Todd Durniak to discuss the company's innovative Dario(TM) Diabetes Management Solution, which offers people with diabetes an opportunity to turn an iPhone or Android phone into a cloud-linked blood glucose management system.
LabStyle Innovations' Dario Diabetes Management System Featured on Numerous American News Outlets
PR Newswire - Thu Sep 17, 7:01AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced the Dario has recently been featured in numerous U.S.-based media outlets including eHealth Radio, Mass Device, Personal Tech MD, and Boston Magazine.
LabStyle Innovations Receives Granted Patent in the U.S. Expanding its IP to Address Management of Chronic Diseases Through Smart Phones
PR Newswire - Wed Sep 09, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), today announced it has been granted a patent from the U.S. Patent and Trademark Office for U.S. Patent No. 9,125,549 on September 8, 2015. The patent titled, "Fluids Testing Apparatus and Methods of Use" broadens and builds upon the IP rights previously granted to Dario in the U.S. through a patent issued in 2014 that addresses how the Dario(TM) blood glucose monitor draws power from and transmits data to a smart phone via the audio jack port. The new patent broadens these claims to include testing of other bodily fluids through an audio jack connection.
LabStyle Innovations to Present at Rodman & Renshaw 17th Annual Global Investment Conference on September 9, 2015
PR Newswire - Thu Sep 03, 7:00AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced the Company will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Wednesday, September 9, 2015. The conference will take place from September 8-10, 2015 at the St. Regis Hotel in New York City. Chairman and Chief Executive Officer Erez Raphael and Chief Financial Officer Zvi Ben-David will present at 4:15pm ET in the Fountainebleau Foyer, 2nd floor. Investors interested in a one-on-one meeting with management, may contact Rodman & Renshaw or contact LabStyle directly regarding scheduling a meeting.
LabStyle Innovations to Exhibit at Australian Diabetes Society's Annual Meeting on August 26 - 28, 2015
PR Newswire - Tue Aug 25, 7:00AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that in conjunction with its Australian distributor, uHealth, the Company is exhibiting at the Australian Diabetes Society (ADS) and Australian Diabetes Educators Association's (ADEA) 2015 Annual Scientific Meeting and Exhibition in Adelaide, Australia. From Wednesday, August 26th through Friday, August 28th, at Booth #9 LabStyle will showcase the Dario Diabetes Management System. The Dario platform is a next generation technology that digitizes every testing event through a miniature meter powered directly by a smartphone via the audio jack turning an iOs or Android smartphone into a cloud-linked meter. In addition to having received regulatory approval in Australia, the Dario is CE marked in Europe and approved in Canada.
LabStyle's Dario Diabetes Device Uses Smartphones to Take Disease Management to its Peak Potential
ACCESSWIRE - Tue Aug 18, 11:48AM CDT
LaLabStyle Innovation's Created All-In-One Blood Glucose Monitor Dario for Diabetics, Turning Smartphones into Glucose Monitors; Device Launch Efforts and Reimbursement Have Shown Rapid Progress outside of the US, FDA Approval Is Sought; Risks Include Continuation and Acceleration of Device Adoption, Regulatory Approvals, and Non-Dilutive Money Raises; Very Low Share Price Belies LabStyle's Value with Respect to the $35.6 Billion Diabetes Treatment Market Size
PNK: 35.53 (-0.26)
LabStyle Innovations Announces 2015 Second Quarter Results
PR Newswire - Thu Aug 13, 7:00AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported financial and operational results for the three-month period ended June 30, 2015, provided an update on recent corporate achievements, and an outlook on upcoming milestones.
LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia
PR Newswire - Wed Jul 29, 8:05AM CDT
CAESAREA, Israel, July 29, 2015 /PRNewswire/-- LabStyle Innovations Corp. (DRIO), today announced that its Dario(TM) Diabetes Management Solution was featured in a national broadcast news segment in Australia. The Dario was recently launched in Australia following regulatory and reimbursement approval in that country.
LabStyle Innovations Featured on the Cover of Opportunist Magazine
PR Newswire - Wed Jul 22, 11:42AM CDT
LabStyle Innovations Corp. (DRIO), today announced that its President & CEO Erez Raphael is featured on the cover of the July 21 issue of Opportunist Magazine. In the feature article Raphael talks with Opportunist's Managing Editor Leslie Stone about LabStyle's Dario(TM) Diabetes Management Solution, an all-in-one glucose meter and cloud-based mobile diabetes management platform. Stone asks Raphael a range of compelling and insightful questions about how the Dario is transforming the diabetes treatment market and the future of LifeStyle Innovations.
LabStyle Innovations' Dario Diabetes Management Solution Now Reimbursed Through a Majority of Medical Plans in Canada
PR Newswire - Tue Jul 14, 8:05AM CDT
LabStyle Innovations Corp. (DRIO), today announced the Dario(TM) Diabetes Management Solution's Smart Meter test strips are now reimbursed in Canada by most private insurance plans after the Dario(TM) was launched in Canada through major pharmacies including London Drugs and online at www.mydario.ca.
LabStyle Innovations appoints Todd Durniak as SVP & GM
M2 - Thu Jul 02, 7:00AM CDT
Diabetes company LabStyle Innovations (OtherOTC
RIO) reported on Wednesday the election of Todd Durniak as senior vice president and general manager of the US.
LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution
PR Newswire - Wed Jul 01, 8:05AM CDT
LabStyle Innovations Corp. (DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced the appointment of Todd Durniak as Senior Vice President and General Manager for the U.S. Durniak brings to LabStyle over 20 years of medical device commercial and technical leadership, most recently as the Vice President and General Manager of Neighborhood Diabetes, a division of Insulet focused on delivering insulin supplies through durable medical equipment (DME) and pharmacy channels with a 'high touch' training approach.
LabStyle Innovations' Dario Diabetes Management Solution Launches in Canada
PR Newswire - Thu Jun 25, 8:00AM CDT
On the heels of receiving regulatory approval in Canada for the Dario(TM) Diabetes Management Solution, LabStyle Innovations Corp. (DRIO), today announced the Dario is now available for sale in Canada. The compact all-in-one system that helps people with diabetes monitor blood sugar levels and proactively manage their disease using their smartphone or tablet, is distributed by Auto Control Medical. Now available through www.mydario.ca, Dario's suggested retail price is $39.95 and it will be available at selected pharmacies including London Drugs.
LabStyle Innovations Late Breaking Poster Presented at American Diabetes Association 75th Scientific Session
PR Newswire - Mon Jun 08, 8:05AM CDT
LabStyle Innovations Corp. (DRIO), developer of the Dario(TM) Diabetes Management Solution, presented a Late Breaking Poster titled, "Performance of Dario Blood Glucose Monitoring System Evaluated in a Clinical Study in Compliance with the New ISO 15197:2013 Standard," at the ADA's 75th Anniversary Scientific Sessions.
LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel
PR Newswire - Tue May 26, 8:05AM CDT
LabStyle Innovations Corp. (DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that in partnership with Israel's leading HMO, Maccabi Healthcare, it has launched the comprehensive Dario(TM) Diabetes Management Solution as part of Maccabi's advanced Telecare unit (MOMA). The Dario(TM) is a proprietary customized diabetes management solution that enables remote treatment for diabetes aiming to improve overall outcomes for patients. Maccabi has integrated the Dario(TM) into MOMA, leveraging LabStyle's cutting edge online and mobile healthcare technologies.
LabStyle Innovations Announces 2015 First Quarter Results
PR Newswire - Fri May 15, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, reported its financial and operational results for the three-month period ended March 31, 2015 and provided an update on recent corporate achievements.
LabStyle Innovations Receives Health Canada Approval for Commercialization of the Dario Diabetes Management Solution
PR Newswire - Thu May 14, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, has announced today that it has been granted Health Canada approval to market and sell Dario(TM) in Canada through their exclusive distributor in Canada Auto Control Medical Inc. ("ACM"
. ACM is a Canadian leader in the category of medical devices for home use, and has successfully launched several blood glucose monitoring systems into the Canadian market over the years. Health Canada is Canada's federal department responsible for helping Canadians maintain their health and the Health Canada approval is a major milestone representing the first sales of Dario in North America.
The Next Big Players in Mobile Health: Apple Watch and Dario
ACCESSWIRE - Mon May 11, 8:01AM CDT
NEW YORK, NY / ACCESSWIRE / May 11, 2015 / The market for mobile health monitoring and diagnostics is projected to reach $8 billion by 2019. Two key players in this market are Apple with its Apple Watch and LabStyle Innovations (OTCQB: DRIO), maker of the Dario Diabetes Management System. This emerging market for small, sleek and often wearable devices that function as mobile healthcare diagnostic devices was estimated at a mere $650 million in 2012. It has been dominated by cardiac monitors that work in conjunction with smart phones. According to Transparency Market Research, the market is expected to grow at a CAGR of 43%, led by growth in the mobile glucose monitoring segment. This is where LabStyle comes in with the Dario.
LabStyle Innovations Launches Online Store for Dario Diabetes Management Solution
PR Newswire - Thu May 07, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported it has opened its first ecommerce store for the Dario Smart meter and Dario accessories. The eShop serves the Israeli market, where the Dario Management Solution was launched in July 2014 following approval from the Israeli Ministry of Health. The Dario has received wide commendations and endorsements from both the medical community and the population of patients in Israel. The shop serves as an excellent channel for LabStyle to sell to people with diabetes and engage with them directly.
LabStyle Innovations to Present at Health 2.0's 9th Annual Fall Conference in Silicon Valley on October 7, 2015
PR Newswire - Wed Sep 30, 7:30AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that its Executive Vice President of U.S. Operations, Todd Durniak, will deliver a demonstration of the Dario Solution at Health 2.0's 9th Annual Fall Conference in Santa Clara, California on Wednesday, October 7, 2015 at 10:45 am PT.
Executive VP of LabStyle Innovations Discusses Firm's Innovative Blood Glucose Testing Technology and His Firm's Current Value Proposition
ACCESSWIRE - Thu Sep 24, 8:01AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 24, 2015 / BioMedReports editor, M.E. Garza recently met with LabStyle Innovations Corp. (OTCQB: DRIO), new Executive Vice President and General Manager of US sales, Todd Durniak to discuss the company's innovative Dario(TM) Diabetes Management Solution, which offers people with diabetes an opportunity to turn an iPhone or Android phone into a cloud-linked blood glucose management system.
LabStyle Innovations' Dario Diabetes Management System Featured on Numerous American News Outlets
PR Newswire - Thu Sep 17, 7:01AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced the Dario has recently been featured in numerous U.S.-based media outlets including eHealth Radio, Mass Device, Personal Tech MD, and Boston Magazine.
LabStyle Innovations Receives Granted Patent in the U.S. Expanding its IP to Address Management of Chronic Diseases Through Smart Phones
PR Newswire - Wed Sep 09, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), today announced it has been granted a patent from the U.S. Patent and Trademark Office for U.S. Patent No. 9,125,549 on September 8, 2015. The patent titled, "Fluids Testing Apparatus and Methods of Use" broadens and builds upon the IP rights previously granted to Dario in the U.S. through a patent issued in 2014 that addresses how the Dario(TM) blood glucose monitor draws power from and transmits data to a smart phone via the audio jack port. The new patent broadens these claims to include testing of other bodily fluids through an audio jack connection.
LabStyle Innovations to Present at Rodman & Renshaw 17th Annual Global Investment Conference on September 9, 2015
PR Newswire - Thu Sep 03, 7:00AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced the Company will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Wednesday, September 9, 2015. The conference will take place from September 8-10, 2015 at the St. Regis Hotel in New York City. Chairman and Chief Executive Officer Erez Raphael and Chief Financial Officer Zvi Ben-David will present at 4:15pm ET in the Fountainebleau Foyer, 2nd floor. Investors interested in a one-on-one meeting with management, may contact Rodman & Renshaw or contact LabStyle directly regarding scheduling a meeting.
LabStyle Innovations to Exhibit at Australian Diabetes Society's Annual Meeting on August 26 - 28, 2015
PR Newswire - Tue Aug 25, 7:00AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that in conjunction with its Australian distributor, uHealth, the Company is exhibiting at the Australian Diabetes Society (ADS) and Australian Diabetes Educators Association's (ADEA) 2015 Annual Scientific Meeting and Exhibition in Adelaide, Australia. From Wednesday, August 26th through Friday, August 28th, at Booth #9 LabStyle will showcase the Dario Diabetes Management System. The Dario platform is a next generation technology that digitizes every testing event through a miniature meter powered directly by a smartphone via the audio jack turning an iOs or Android smartphone into a cloud-linked meter. In addition to having received regulatory approval in Australia, the Dario is CE marked in Europe and approved in Canada.
LabStyle's Dario Diabetes Device Uses Smartphones to Take Disease Management to its Peak Potential
ACCESSWIRE - Tue Aug 18, 11:48AM CDT
LaLabStyle Innovation's Created All-In-One Blood Glucose Monitor Dario for Diabetics, Turning Smartphones into Glucose Monitors; Device Launch Efforts and Reimbursement Have Shown Rapid Progress outside of the US, FDA Approval Is Sought; Risks Include Continuation and Acceleration of Device Adoption, Regulatory Approvals, and Non-Dilutive Money Raises; Very Low Share Price Belies LabStyle's Value with Respect to the $35.6 Billion Diabetes Treatment Market Size
PNK: 35.53 (-0.26)
LabStyle Innovations Announces 2015 Second Quarter Results
PR Newswire - Thu Aug 13, 7:00AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported financial and operational results for the three-month period ended June 30, 2015, provided an update on recent corporate achievements, and an outlook on upcoming milestones.
LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia
PR Newswire - Wed Jul 29, 8:05AM CDT
CAESAREA, Israel, July 29, 2015 /PRNewswire/-- LabStyle Innovations Corp. (DRIO), today announced that its Dario(TM) Diabetes Management Solution was featured in a national broadcast news segment in Australia. The Dario was recently launched in Australia following regulatory and reimbursement approval in that country.
LabStyle Innovations Featured on the Cover of Opportunist Magazine
PR Newswire - Wed Jul 22, 11:42AM CDT
LabStyle Innovations Corp. (DRIO), today announced that its President & CEO Erez Raphael is featured on the cover of the July 21 issue of Opportunist Magazine. In the feature article Raphael talks with Opportunist's Managing Editor Leslie Stone about LabStyle's Dario(TM) Diabetes Management Solution, an all-in-one glucose meter and cloud-based mobile diabetes management platform. Stone asks Raphael a range of compelling and insightful questions about how the Dario is transforming the diabetes treatment market and the future of LifeStyle Innovations.
LabStyle Innovations' Dario Diabetes Management Solution Now Reimbursed Through a Majority of Medical Plans in Canada
PR Newswire - Tue Jul 14, 8:05AM CDT
LabStyle Innovations Corp. (DRIO), today announced the Dario(TM) Diabetes Management Solution's Smart Meter test strips are now reimbursed in Canada by most private insurance plans after the Dario(TM) was launched in Canada through major pharmacies including London Drugs and online at www.mydario.ca.
LabStyle Innovations appoints Todd Durniak as SVP & GM
M2 - Thu Jul 02, 7:00AM CDT
Diabetes company LabStyle Innovations (OtherOTC
RIO) reported on Wednesday the election of Todd Durniak as senior vice president and general manager of the US. LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution
PR Newswire - Wed Jul 01, 8:05AM CDT
LabStyle Innovations Corp. (DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced the appointment of Todd Durniak as Senior Vice President and General Manager for the U.S. Durniak brings to LabStyle over 20 years of medical device commercial and technical leadership, most recently as the Vice President and General Manager of Neighborhood Diabetes, a division of Insulet focused on delivering insulin supplies through durable medical equipment (DME) and pharmacy channels with a 'high touch' training approach.
LabStyle Innovations' Dario Diabetes Management Solution Launches in Canada
PR Newswire - Thu Jun 25, 8:00AM CDT
On the heels of receiving regulatory approval in Canada for the Dario(TM) Diabetes Management Solution, LabStyle Innovations Corp. (DRIO), today announced the Dario is now available for sale in Canada. The compact all-in-one system that helps people with diabetes monitor blood sugar levels and proactively manage their disease using their smartphone or tablet, is distributed by Auto Control Medical. Now available through www.mydario.ca, Dario's suggested retail price is $39.95 and it will be available at selected pharmacies including London Drugs.
LabStyle Innovations Late Breaking Poster Presented at American Diabetes Association 75th Scientific Session
PR Newswire - Mon Jun 08, 8:05AM CDT
LabStyle Innovations Corp. (DRIO), developer of the Dario(TM) Diabetes Management Solution, presented a Late Breaking Poster titled, "Performance of Dario Blood Glucose Monitoring System Evaluated in a Clinical Study in Compliance with the New ISO 15197:2013 Standard," at the ADA's 75th Anniversary Scientific Sessions.
LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel
PR Newswire - Tue May 26, 8:05AM CDT
LabStyle Innovations Corp. (DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that in partnership with Israel's leading HMO, Maccabi Healthcare, it has launched the comprehensive Dario(TM) Diabetes Management Solution as part of Maccabi's advanced Telecare unit (MOMA). The Dario(TM) is a proprietary customized diabetes management solution that enables remote treatment for diabetes aiming to improve overall outcomes for patients. Maccabi has integrated the Dario(TM) into MOMA, leveraging LabStyle's cutting edge online and mobile healthcare technologies.
LabStyle Innovations Announces 2015 First Quarter Results
PR Newswire - Fri May 15, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, reported its financial and operational results for the three-month period ended March 31, 2015 and provided an update on recent corporate achievements.
LabStyle Innovations Receives Health Canada Approval for Commercialization of the Dario Diabetes Management Solution
PR Newswire - Thu May 14, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, has announced today that it has been granted Health Canada approval to market and sell Dario(TM) in Canada through their exclusive distributor in Canada Auto Control Medical Inc. ("ACM"
. ACM is a Canadian leader in the category of medical devices for home use, and has successfully launched several blood glucose monitoring systems into the Canadian market over the years. Health Canada is Canada's federal department responsible for helping Canadians maintain their health and the Health Canada approval is a major milestone representing the first sales of Dario in North America. The Next Big Players in Mobile Health: Apple Watch and Dario
ACCESSWIRE - Mon May 11, 8:01AM CDT
NEW YORK, NY / ACCESSWIRE / May 11, 2015 / The market for mobile health monitoring and diagnostics is projected to reach $8 billion by 2019. Two key players in this market are Apple with its Apple Watch and LabStyle Innovations (OTCQB: DRIO), maker of the Dario Diabetes Management System. This emerging market for small, sleek and often wearable devices that function as mobile healthcare diagnostic devices was estimated at a mere $650 million in 2012. It has been dominated by cardiac monitors that work in conjunction with smart phones. According to Transparency Market Research, the market is expected to grow at a CAGR of 43%, led by growth in the mobile glucose monitoring segment. This is where LabStyle comes in with the Dario.
LabStyle Innovations Launches Online Store for Dario Diabetes Management Solution
PR Newswire - Thu May 07, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported it has opened its first ecommerce store for the Dario Smart meter and Dario accessories. The eShop serves the Israeli market, where the Dario Management Solution was launched in July 2014 following approval from the Israeli Ministry of Health. The Dario has received wide commendations and endorsements from both the medical community and the population of patients in Israel. The shop serves as an excellent channel for LabStyle to sell to people with diabetes and engage with them directly.
